Brian Park, PharmD

Drug Information Specialist https://www.clinicalpainadvisor.com

Brian Park, PharmD, is a Drug Information Specialist at MPR. A graduate of the Ernest Mario School of Pharmacy, Rutgers University, Brian worked as a pharmacy manager at Stop & Shop Pharmacy for 8 years. He is a certified diabetes care pharmacist.

All articles by Brian Park, PharmD

General Medicine

Statin Use Linked to Reduced Death Risk in Hospitalized COVID-19 Patients

Brian Park, PharmD

July 23, 2021

Study authors analyzed data from 10,541 hospitalized patients with active COVID-19 disease to evaluate the relationship between the use of statins and COVID-19 outcomes.

General Pain

Fentanyl 50mcg/mL Ready-to-Use Prefilled Syringes Now Available

Brian Park, PharmD

July 9, 2021

The Simplist ready-to-administer prefilled syringes require no assembly or point-of-care preparation.

Practice Management

Risk of Falsely Low Results Prompts Recall of Lead Tests

Brian Park, PharmD

July 9, 2021

The FDA is concerned that obtaining falsely low test results may lead to inappropriate follow-up assessments, which may result in patient harm.

Acute Pain

Bupivacaine and Meloxicam Now Available for Postsurgical Analgesia for Up to 72 Hours

Brian Park, PharmD

July 8, 2021

Zynrelef is a dual-acting local anesthetic that delivers a fixed-dose combination of bupivacaine, an amide local anesthetic, and meloxicam, an NSAID.

Migraine & Headache

Study Compares Remote Electrical Neuromodulation to Migraine Medication in Adolescents

Brian Park, PharmD

July 7, 2021

Nerivio is a wireless remote electrical neuromodulation device approved for the acute treatment of episodic or chronic migraine in patients 12 years of age and older.

General Pain

FDA Issues Complete Response Letter for Burn Therapy NexoBrid

Brian Park, PharmD

July 6, 2021

NexoBrid is a topically administered, bromelain-based biological product containing a sterile mixture of proteolytic enzymes.

Practice Management

FDA Clears Wearable, Wireless Thermometer for Prescription, OTC Use

Brian Park, PharmD

June 30, 2021

The FDA has granted 510(k) clearance to Radius Tº, a wearable, wireless thermometer to measure body temperature for both prescription and over-the-counter use in individuals 5 years of age and older.

General Pain

Remdesivir Cuts Mortality Risk in Hospitalized COVID-19 Patients, According to Real-World Data

Brian Park, PharmD

June 30, 2021

Veklury is currently approved for the treatment of COVID-19 in patients aged 12 years and older (weighing at least 40kg) requiring hospitalization.

Practice Management

FDA: Systemic Side Effects Reported After Hand Sanitizer Application

Brian Park, PharmD

June 28, 2021

The Agency reviewed case reports from the FAERS database and calls from US poison control centers related to systemic symptoms after applying alcohol-based hand sanitizers to the skin.

General Pain

Novavax COVID-19 Vaccine Highly Effective in Pivotal Phase 3 Trial

Brian Park, PharmD

June 21, 2021

The pivotal phase 3 PREVENT-19 trial evaluated the efficacy, safety and immunogenicity of NVX-CoV2373 in 29,960 participants 18 years of age and older in the US and Mexico.

Next post in General Pain